Phase 2CompletedAge-related condition
Study of ATH434 in Participants with Multiple System Atrophy
A Randomized, Double-Blind, Placebo-Controlled Study of ATH434 in Multiple System Atrophy
- Sponsor
- Alterity Therapeutics (Industry)
- Enrolment
- 77 enrolled
- Conditions
- Multiple System Atrophy
- Interventions
- ATH434 dose level 1; ATH434 dose level 2; Placebo
- Ages
- adults, older adults
- Registry
- NCT05109091
Full record on ClinicalTrials.gov
From the registry
This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy
Primary outcomes
- Change in iron content as measured by brain MRI
History
Last registry update
Primary completion
Started
Registered